Guru Ownership Trend
Guru Analysis for Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $20.05 M.
Top institutional holders include Jefferies Group and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $5.13 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, John Hussman reduced exposure by 46.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Tarsus Pharmaceuticals, Inc. (TARS)
Major holders include Jefferies Group ($9.73 M), Renaissance Technologies (RenTech) ($5.25 M), Steven Cohen ($3.08 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 285,961 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $5.13 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited TARS. The total reported sell value was $2.12 M.
Yes, 2 managers opened new positions in TARS, and 2 increased their existing holdings. The total reported buy value was $7.25 M.